Clinical trials
Observational Eczema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 11 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 18 |
| Unknown status | 12 |
| Active, not recruiting | 7 |
| Not yet recruiting | 6 |
| Enrolling by invitation | 4 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Bandim Health Project | 2 |
| Hôpitaux Drôme Nord | 2 |
| Incyte Corporation | 2 |
| King's College London | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| ProgenaBiome | 2 |
| University of California, San Francisco | 2 |
| Agentschap NL | 1 |
| Almirall, S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eczema | 77 |
| Dermatitis, Atopic | 46 |
| Psoriasis | 13 |
| Asthma | 12 |
| Dermatitis | 8 |
| Hypersensitivity | 8 |
| Neoplasms | 6 |
| Acne Vulgaris | 5 |
| Diabetes Mellitus | 5 |
| Food Hypersensitivity | 5 |
Trials
Showing 26 to 50 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.